Top Page
Barclays (BARC) vs. S&P 500 (SPY)
Barclays Business Overview & Revenue Model
Barclays Financial Statement Overview
| Breakdown | |||||
| TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
| Income Statement | Total Revenue | ||||
| 25.43B | 26.23B | 23.50B | 24.96B | 21.94B | 21.77B | Gross Profit |
| 25.43B | 26.23B | 25.38B | 24.96B | 21.94B | 21.77B | EBIT |
| 4.14B | 0.00 | 7.42B | 15.49B | 8.37B | 2.99B | EBITDA |
| 2.06B | 0.00 | 0.00 | 8.73B | 9.61B | 4.60B | Net Income Common Stockholders |
| 4.97B | 6.31B | 5.26B | 5.93B | 7.01B | 2.38B |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
| 265.87B | 210.18B | 220.88B | 256.35B | 238.57B | 191.13B | Total Assets |
| 1.54T | 1.52T | 1.48T | 1.51T | 1.38T | 1.35T | Total Debt |
| 126.72B | 0.00 | 150.55B | 124.30B | 111.63B | 92.14B | Net Debt |
| -139.16B | -210.18B | -70.33B | -132.05B | -126.95B | -98.99B | Total Liabilities |
| 126.72B | 1.45T | 1.41T | 1.44T | 111.63B | 92.14B | Stockholders Equity |
| 69.70B | 71.82B | 71.20B | 68.29B | 69.22B | 65.80B |
| Cash Flow | Free Cash Flow | ||||
| 0.00 | 5.54B | -2.65B | 28.48B | 47.20B | 56.18B | Operating Cash Flow |
| 0.00 | 7.11B | -927.00M | 30.23B | 48.92B | 57.51B | Investing Cash Flow |
| 0.00 | -17.89B | -23.41B | -21.67B | 4.27B | -18.38B | Financing Cash Flow |
| 0.00 | 784.00M | -8.35B | 696.00M | 107.00M | 2.73B |
Barclays Technical Analysis
Barclays Risk Analysis
Barclays Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | £163.15B | 9.38 | 12.96% | 5.29% | 3.98% | 5.43% | |
75 Outperform | £44.68B | 8.63 | 8.78% | 2.87% | 5.56% | 31.39% | |
75 Outperform | £43.29B | 11.35 | 11.19% | 4.01% | 31.97% | -21.96% | |
71 Outperform | £38.66B | 8.98 | 12.20% | 3.64% | 15.69% | 11.47% | |
64 Neutral | $14.34B | 10.61 | 9.28% | 4.07% | 18.04% | -9.54% |
Barclays Earnings Call Summary
Barclays Corporate Events
Barclays PLC has announced the repurchase and cancellation of 1,961,000 of its ordinary shares as part of its ongoing buy-back program initiated on 14 February 2025. This move is part of a broader strategy to manage its capital structure and enhance shareholder value, with a total of 46,031,285 shares purchased since the program’s inception. The cancellation of these shares will adjust the company’s issued share capital to 14,377,584,418 ordinary shares, impacting shareholder calculations under the FCA’s Disclosure Guidance and Transparency Rules.
Barclays PLC has announced the repurchase and cancellation of 2,827,000 of its ordinary shares on the London Stock Exchange, as part of a buy-back program initiated on 14 February 2025. This move, which follows the purchase of over 44 million shares since the program’s commencement, aims to reduce the company’s share capital and potentially enhance shareholder value by increasing the proportionate ownership of remaining shares.
Barclays PLC announced that as of 28 February 2025, its issued share capital consists of 14,382,253,906 ordinary shares with voting rights, with none held in treasury. This figure is crucial for shareholders and those with notification obligations to determine their interest in Barclays under the FCA’s Disclosure Guidance and Transparency Rules.
Barclays PLC has applied for the block listing of 20 million ordinary shares on the London Stock Exchange, under its Group Share Value Plan. The shares, which will rank equally with existing shares, are expected to be admitted for trading on March 4, 2025, potentially enhancing the company’s market liquidity and shareholder value.
Barclays PLC has announced the purchase and cancellation of 2,885,000 of its ordinary shares on the London Stock Exchange as part of its ongoing buy-back program. This move is part of a broader strategy to manage its capital structure and return value to shareholders, with a total of 41,243,285 shares repurchased since the program’s commencement, potentially impacting shareholder calculations under the FCA’s Disclosure Guidance and Transparency Rules.
Barclays PLC has executed a share buy-back program, purchasing 2,848,500 of its ordinary shares for cancellation, as part of a previously announced initiative. This move reduces the company’s issued share capital to 14,385,107,275 shares, potentially impacting shareholder calculations under the FCA’s rules, and reflects Barclays’ strategic efforts to manage its equity structure.
Barclays PLC announced a transaction involving the disposal of shares by Taylor Wright, the Global Co-Head of Investment Banking, as part of the company’s nominee service managed by Solium Capital UK Limited. The transaction, which involved 27,163 shares at a price of £3.017 each, took place on the London Stock Exchange and reflects ongoing managerial activities within the company, potentially impacting shareholder perceptions and market dynamics.
Barclays PLC announced the repurchase and cancellation of 5,185,000 of its ordinary shares as part of its ongoing buy-back program. This move, aimed at reducing the number of shares in circulation, will adjust the company’s issued share capital to 14,387,920,127 ordinary shares with voting rights, potentially impacting shareholder calculations and interests under regulatory guidelines.
Barclays PLC has announced the availability of a prospectus supplement related to the issuance of $1.5 billion in 7.625% Fixed Rate Resetting Perpetual Subordinated Contingent Convertible Securities. This financial move is part of Barclays’ strategy to strengthen its capital base and enhance its financial flexibility, potentially impacting its market positioning and offering implications for investors and stakeholders.
Barclays PLC has executed a share buy-back program, purchasing 5.1 million of its own shares for cancellation, as part of an initiative announced earlier in February 2025. This move is aimed at reducing the total number of shares in circulation, thereby potentially increasing the value of remaining shares and enhancing shareholder value. The cancellation of these shares will adjust the company’s issued share capital to approximately 14.4 billion shares, which stakeholders can use for regulatory notification purposes.
Barclays PLC announced the purchase and cancellation of 5,100,000 of its ordinary shares as part of its buy-back program. This move is part of a broader strategy to manage its share capital and could potentially impact shareholder value by reducing the number of shares in circulation, thus increasing the value of remaining shares.
Barclays PLC announced the repurchase of 2,871,846 of its ordinary shares on the London Stock Exchange, as part of its ongoing buy-back program initiated on 14 February 2025. This move is expected to reduce the company’s share capital to 14,406,016,158 shares and could potentially enhance shareholder value by decreasing the number of shares in circulation.
Barclays PLC has announced the purchase and cancellation of 1,980,000 ordinary shares as part of its ongoing share buy-back program, which began on 14 February 2025. This move aims to reduce the company’s share capital, thereby potentially increasing shareholder value and adjusting the denominator for shareholder interest calculations under regulatory guidelines.
Barclays PLC announced the repurchase and cancellation of 1,986,825 of its ordinary shares from J.P. Morgan Securities plc as part of its ongoing buy-back program. This move, which follows a previous announcement on 14 February 2025, reduces the company’s issued share capital to 14,410,729,298 ordinary shares. The buy-back program aims to enhance shareholder value and optimize the capital structure of the company, reflecting Barclays’ commitment to returning excess capital to shareholders while maintaining regulatory compliance.
Barclays PLC announced the acquisition of shares by its Non-Executive Directors and Group Chairman as part of their compensation policy. This policy involves using a portion of the directors’ fees to purchase shares, which are retained until they leave the board, aligning their interests with those of shareholders. The transactions were conducted on the London Stock Exchange, and this approach aims to enhance stakeholder alignment and strengthen corporate governance by ensuring that directors have a vested interest in the company’s performance.
Barclays PLC announced the purchase and cancellation of 5.1 million of its ordinary shares as part of its ongoing buy-back program, which commenced on 14 February 2025. This strategic move is aimed at reducing the total share count to 14.4 billion shares, potentially enhancing shareholder value and reflecting the company’s confidence in its financial health and future prospects.
Barclays PLC has announced the repurchase and cancellation of over 5 million of its ordinary shares as part of a buy-back program. This move is expected to reduce the total number of shares in circulation, allowing shareholders to adjust their stakes and maintain compliance with regulatory guidelines, potentially impacting share value positively.
Barclays PLC has filed its 2024 Annual Report on Form 20-F with the US Securities and Exchange Commission, making it available online and through the National Storage Mechanism for inspection. This filing ensures transparency and accessibility of Barclays’ financial performance and operations to its shareholders, including those holding American Depositary Receipts, who can request audited financial statements at no charge.
Barclays PLC has announced the commencement of a £1,000 million share buy-back program starting 14 February 2025, with the goal of reducing its share capital. J.P. Morgan Securities plc will conduct the buy-back on behalf of Barclays, making independent trading decisions within regulatory parameters. This initiative is set to conclude by 13 November 2025, contingent on regulatory approval, and reflects Barclays’ strategic financial management efforts to enhance shareholder value.
Barclays has released its 2024 Annual Report and Accounts, along with the 2024 Pillar 3 Report. These documents are now available for inspection through the National Storage Mechanism and the company’s website. This release is part of Barclays’ efforts to maintain transparency with its stakeholders and complies with regulatory requirements. The reports provide comprehensive insights into the company’s financial performance and governance practices for the year 2024.
Barclays PLC announced its 2024 financial results, achieving a return on tangible equity of 10.5% and distributing £3.0 billion in capital, including a £1.0 billion buyback. The company saw a 24% increase in profit before tax to £8.1 billion and an earnings per share rise of 8.3p to 36.0p, demonstrating successful execution of its three-year plan and aligning with its 2026 targets.
Barclays PLC has announced its total issued share capital, which consists of 14,421,517,527 ordinary shares with voting rights as of January 31, 2025. This information is crucial for shareholders and entities with notification obligations under the FCA’s Disclosure Guidance, as it serves as the denominator for calculating changes in share interest, thereby impacting investor relations and market transparency.
Barclays PLC has completed the sale of its German consumer finance business to BAWAG P.S.K., a subsidiary of BAWAG Group AG. This strategic move is intended to simplify Barclays’ operations and focus on expanding its key business segments, releasing approximately €4.0bn of risk-weighted assets and increasing the CET1 ratio by about 10 basis points, thus strengthening its financial position.
Barclays has announced changes to its board as part of its long-term succession planning. Diane Schueneman will retire from several key roles, while Brian Shea will take over as Chair of Barclays Execution Services Limited, bringing over 40 years of financial services experience to the position. Additionally, Nigel Higgins, Group Chairman, joins the Board Remuneration Committees, marking further strategic adjustments in the company’s leadership. These changes reflect Barclays’ strategic focus on strengthening its governance and operational leadership, potentially impacting its market positioning and stakeholder relations.
Barclays PLC announced the availability of the final terms for its issuance of GBP 750,000,000 Fixed Rate Resetting Senior Callable Notes due 31 July 2032, as part of the Barclays PLC Debt Issuance Programme. This issuance reflects Barclays’ strategic approach to managing its long-term debt obligations and maintaining a robust capital structure, potentially impacting its financial stability and offering insights into its future operational strategies.
Barclays PLC has announced the full redemption of its EUR 1,000,000,000 1.375% Reset Notes due 2026, effective 24 January 2025. This move includes canceling the Notes’ listing on the FCA Official List and their trading on the London Stock Exchange, indicating a strategic financial decision likely impacting the company’s debt structure and market operations.
Barclays PLC announced transactions involving shares carried out by several key executives as part of their remuneration packages. These transactions, executed on the London Stock Exchange, involve both the delivery of shares as part of fixed remuneration and the sale of shares to cover tax liabilities. The shares delivered are subject to a holding period with restrictions lifting in equal tranches over five years, which could impact the liquidity and financial planning of the executives involved.
Barclays PLC has announced its plan to initiate a formal tender process for selecting its statutory auditor starting from the 2027 financial year. Currently audited by KPMG LLP since 2017, Barclays will begin this process in the first quarter of 2025, overseen by its Board Audit Committee, with a decision expected by June 2025. This move signals Barclays’ commitment to maintaining transparency and accountability in its financial reporting, potentially impacting its audit practices and relationships with stakeholders.
Barclays PLC announced a transaction involving its CEO for Barclays US Consumer Bank and Barclays Bank Delaware, Denny Nealon. The transaction involved the delivery of American Depositary Shares (ADSs) as part of a Global Share Purchase Plan, highlighting Barclays’ ongoing commitment to incentivizing its executives and aligning their interests with shareholders.
Barclays PLC has completed its share buy-back program, acquiring a total of 320 million shares for cancellation, with the final transaction involving 1.56 million shares purchased at an average price of 265.61 pence. This move reduces the company’s share capital to approximately 14.4 billion shares. The buy-back, which started in August, involved a total expenditure of about £750 million.
Barclays PLC has repurchased and cancelled nearly 5 million of its ordinary shares as part of a buy-back program, reducing its total share capital to over 14.4 billion shares. This move is part of a larger strategy initiated in August 2024, which has seen the company buy back over 318 million shares at an average price of 234.04p each. Such buy-backs can potentially enhance shareholder value by reducing the number of shares outstanding.